In our study, although knockdown of COX-2 dramatically inhibited EGF-induced fibronectin expression, we found that knockdown of fibronectin had no effect on COX-2 expression in EGF-treated HNSCC cells. This evidence concerns the gene FN1 and head and neck squamous cell carcinoma.